相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Durvalumab plus tremelimumab alone or in combination with low-dose or hypofractionated radiotherapy in metastatic non-small-cell lung cancer refractory to previous PD(L)-1 therapy: an open-label, multicentre, randomised, phase 2 trial
Jonathan D. Schoenfeld et al.
LANCET ONCOLOGY (2022)
The prognosis of HPV-associated metastatic pharyngeal patients by primary and distant site
Juncheng Wang et al.
ORAL ONCOLOGY (2022)
Detection of Occult Recurrence Using Circulating Tumor Tissue Modified Viral HPV DNA among Patients Treated for HPV-Driven Oropharyngeal Carcinoma
Barry M. Berger et al.
CLINICAL CANCER RESEARCH (2022)
Head and Neck Cancers, Version 1.2022 Featured Updates to the NCCN Guidelines
Jimmy J. Caudell et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2022)
Randomized Phase II Trial of Nivolumab With Stereotactic Body Radiotherapy Versus Nivolumab Alone in Metastatic Head and Neck Squamous Cell Carcinoma
Sean McBride et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Metastasis-directed stereotactic body radiation therapy in the management of oligometastatic head and neck cancer
Ciro Franzese et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2021)
Identifying an oligometastatic phenotype in HPV-associated oropharyngeal squamous cell cancer: Implications for clinical trial design
Christopher W. Fleming et al.
ORAL ONCOLOGY (2021)
Definitive tumor directed therapy confers a survival advantage for metachronous oligometastatic HPV-associated oropharyngeal cancer following trans-oral robotic surgery
Christopher M. Wright et al.
ORAL ONCOLOGY (2021)
Ablative radiation therapy to restrain everything safely treatable (ARREST): study protocol for a phase I trial treating polymetastatic cancer with stereotactic radiotherapy
Glenn S. Bauman et al.
BMC CANCER (2021)
Oligometastatic head and neck cancer: Which patients benefit from radical local treatment of all tumour sites?
Thomas Weissmann et al.
RADIATION ONCOLOGY (2021)
Distinct Outcomes of Oropharyngeal Squamous Cell Carcinoma Patients after Distant Failure According to p16 Status: Implication in Therapeutic Options
Anouchka Modesto et al.
CURRENT ONCOLOGY (2021)
Radiotherapy and Immunotherapy for Cancer: From Systemic to Multisite
Ainhoa Arina et al.
CLINICAL CANCER RESEARCH (2020)
Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation
Matthias Guckenberger et al.
LANCET ONCOLOGY (2020)
Efficacy and Safety of Locoregional Radiotherapy With Chemotherapy vs Chemotherapy Alone in De Novo Metastatic Nasopharyngeal Carcinoma A Multicenter Phase 3 Randomized Clinical Trial
Rui You et al.
JAMA ONCOLOGY (2020)
Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document
Yolande Lievens et al.
RADIOTHERAPY AND ONCOLOGY (2020)
Pembrolizumab with or without radiotherapy for metastatic non-small-cell lung cancer: a pooled analysis of two randomised trials
Willemijn S M E Theelen et al.
Lancet Respiratory Medicine (2020)
Initial Results of a Multicenter Phase 2 Trial of Stereotactic Ablative Radiation Therapy for Oligometastatic Cancer
Philip Sutera et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)
Immunotherapy for small cell lung cancer: mechanisms of resistance
Gerhard Hamilton et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2019)
Oligometastatic squamous cell carcinoma of the head and neck treated with stereotactic body ablative radiotherapy: Single-institution outcomes
James E. Bates et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2019)
Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non-Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study
Daniel R. Gomez et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial
David A. Palma et al.
LANCET (2019)
Detection of Solid Tumor Molecular Residual Disease(MRD) Using Circulating Tumor DNA (ctDNA)
Re-I Chin et al.
MOLECULAR DIAGNOSIS & THERAPY (2019)
Clinical outcome of stereotactic body radiotherapy for lung-only oligometastatic head and neck squamous cell carcinoma: Is the deferral of systemic therapy a potential goal?
Pierluigi Bonomo et al.
ORAL ONCOLOGY (2019)
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)
Ezra E. W. Cohen et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Patterns of failure after immunotherapy with checkpoint inhibitors predict durable progression-free survival after local therapy for metastatic melanoma
Nicholas D. Klemen et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
Barbara Burtness et al.
LANCET (2019)
Treatment Strategy for Distant Synchronous Metastatic Head and Neck Squamous Cell Carcinoma
Eliane Tang et al.
CURRENT ONCOLOGY REPORTS (2019)
Dual-energy computed tomography for prediction of loco-regional recurrence after radiotherapy in larynx and hypopharynx squamous cell carcinoma
Houda Bahig et al.
EUROPEAN JOURNAL OF RADIOLOGY (2019)
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study
Ezra E. W. Cohen et al.
LANCET (2019)
Plasma HPV cell-free DNA monitoring in advances HPV-associates oropharyngeal cancer
G. J. Hanna et al.
ANNALS OF ONCOLOGY (2018)
Improved overall survival in head and neck cancer patients after specific therapy of distant metastases
Dominik Schulz et al.
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2018)
Oligometastatic status as predictor of survival in metastatic human papillomavirus-positive oropharyngeal carcinoma
William G. Albergotti et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2018)
Nivolumab vs investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression
Robert L. Ferris et al.
ORAL ONCOLOGY (2018)
Investigation of radiomic signatures for local recurrence using primary tumor texture analysis in oropharyngeal head and neck cancer patients
Hesham Elhalawani et al.
SCIENTIFIC REPORTS (2018)
Combining radiation plus immunotherapy to improve systemic immune response
Taylor R. Cushman et al.
JOURNAL OF THORACIC DISEASE (2018)
Liquid biopsy of cancer: a multimodal diagnostic tool in clinical oncology
Raffaele Palmirotta et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2018)
SBRT for oligoprogressive oncogene addicted NSCLC
L. Basler et al.
LUNG CANCER (2017)
Radiotherapy and immunotherapy: a beneficial liaison?
Ralph R. Weichselbaum et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Distant Metastases Following Postoperative Intensity-Modulated Radiotherapy for Oral Cavity Squamous Cell Carcinoma
Ali Hosni et al.
JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY (2017)
Patterns of Treatment Failure and Postrecurrence Outcomes Among Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma After Chemoradiotherapy Using Modern Radiation Techniques
Jonathan E. Leeman et al.
JAMA ONCOLOGY (2017)
Study of diffusion weighted MRI as a predictive biomarker of response during radiotherapy for high and intermediate risk squamous cell cancer of the oropharynx: The MeRInO study
C. Paterson et al.
CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY (2017)
Stereotactic Body Radiation Therapy for Treatment of Spinal Bone Metastasis
Yasemin Benderli Cihan
Asian Pacific Journal of Cancer Prevention (2016)
Oligometastases in AJCC stage IVc nasopharyngeal carcinoma: A subset with better overall survival
Yun-hong Tian et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2016)
Image-based Multilevel Subdivision of M1 Category in TNM Staging System for Metastatic Nasopharyngeal Carcinoma
Lujun Shen et al.
RADIOLOGY (2016)
Radiomics: Images Are More than Pictures, They Are Data
Robert J. Gillies et al.
RADIOLOGY (2016)
Diagnostic and Prognostic Value of Circulating Tumor Cells in Head and Neck Squamous Cell Carcinoma: a systematic review and meta-analysis
Xiang-Lei Wu et al.
SCIENTIFIC REPORTS (2016)
Ablative Tumor Radiation Can Change the Tumor Immune Cell Microenvironment to Induce Durable Complete Remissions
Alexander Filatenkov et al.
CLINICAL CANCER RESEARCH (2015)
Resection of subsequent pulmonary metastases from treated head and neck squamous cell carcinoma: systematic review and meta-analysis
E. R. Young et al.
CLINICAL OTOLARYNGOLOGY (2015)
Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomas
Yuxuan Wang et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
The biology and treatment of oligometastatic cancer
Diane K. Reyes et al.
ONCOTARGET (2015)
Effect of Human Papillomavirus on Patterns of Distant Metastatic Failure in Oropharyngeal Squamous Cell Carcinoma Treated With Chemoradiotherapy
Samuel J. Trosman et al.
JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY (2015)
Abscopal Effects: Case Report and Emerging Opportunities
Michael Lock et al.
CUREUS JOURNAL OF MEDICAL SCIENCE (2015)
Distant metastasis in p16-positive oropharyngeal squamous cell carcinoma: A critical analysis of patterns and outcomes
P. Sinha et al.
ORAL ONCOLOGY (2014)
Long-term survival after distant metastasis in patients with oropharyngeal cancer
Sean M. McBride et al.
ORAL ONCOLOGY (2014)
Retrospective Analysis of 234 Nasopharyngeal Carcinoma Patients with Distant Metastasis at Initial Diagnosis: Therapeutic Approaches and Prognostic Factors
Lei Zeng et al.
PLOS ONE (2014)
Saliva and Plasma Quantitative Polymerase Chain Reaction-Based Detection and Surveillance of Human Papillomavirus-Related Head and Neck Cancer
Sun M. Ahn et al.
JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY (2014)
Radiation fosters dose-dependent and chemotherapy-induced immunogenic cell death
Encouse B. Golden et al.
ONCOIMMUNOLOGY (2014)
Deintensification Candidate Subgroups in Human Papillomavirus-Related Oropharyngeal Cancer According to Minimal Risk of Distant Metastasis
Brian O'Sullivan et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Natural course of distant metastases following radiotherapy or chemoradiotherapy in HPV-related oropharyngeal cancer
Shao Hui Huang et al.
ORAL ONCOLOGY (2013)
Stereotactic body radiotherapy for multisite extracranial oligometastases Final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease
Joseph K. Salama et al.
CANCER (2012)
The Canadian Association of Radiation Oncology Scope of Practice Guidelines for Lung, Liver and Spine Stereotactic Body Radiotherapy
A. Sahgal et al.
CLINICAL ONCOLOGY (2012)
ATYPICAL CLINICAL BEHAVIOR OF p16-CONFIRMED HPV-RELATED OROPHARYNGEAL SQUAMOUS CELL CARCINOMA TREATED WITH RADICAL RADIOTHERAPY
Shao Hui Huang et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma
Michael A. Postow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Distant metastases from head and neck squamous cell carcinoma. Part I. Basic aspects
Robert P. Takes et al.
ORAL ONCOLOGY (2012)
Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial
M. R. Posner et al.
ANNALS OF ONCOLOGY (2011)
SQUAMOUS CELL CANCER OF THE HEAD AND NECK WITH DISTANT METASTASIS AT PRESENTATION
David I. Kuperman et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2011)
STEREOTACTIC BODY RADIOTHERAPY (SBRT) FOR OPERABLE STAGE I NON SMALL-CELL LUNG CANCER: CAN SBRT BE COMPARABLE TO SURGERY?
Hiroshi Onishi et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
Oligometastases revisited
Ralph R. Weichselbaum et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Cell-free nucleic acids as biomarkers in cancer patients
Heidi Schwarzenbach et al.
NATURE REVIEWS CANCER (2011)
Positron Emission Tomography With [18F]Fluorodeoxyglucose Improves Staging and Patient Management in Patients With Head and Neck Squamous Cell Carcinoma: A Multicenter Prospective Study
Max Lonneux et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Stereotactic body radiation therapy: a novel treatment modality
Simon S. Lo et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment
Youjin Lee et al.
BLOOD (2009)
Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Lung Metastases
Kyle E. Rusthoven et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: Updated results of 257 patients in a Japanese multi-institutional study
Hiroshi Onishi et al.
JOURNAL OF THORACIC ONCOLOGY (2007)
Distant metastases in head and neck carcinoma: Identification of prognostic groups with MR imaging
Redina Ljumanovic et al.
EUROPEAN JOURNAL OF RADIOLOGY (2006)
Stereotactic hypofractionated radiotherapy for stage I non-small cell lung cancer - Mature results for medically inoperable patients
J Nyman et al.
LUNG CANCER (2006)
Clinical outcomes of stereotactic radiotherapy for stage I non-small cell lung cancer using a novel irradiation technique: patient self-controlled breath-hold and beam switching using a combination of linear accelerator and CT scanner
H Onishi et al.
LUNG CANCER (2004)
Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases
WJ Allard et al.
CLINICAL CANCER RESEARCH (2004)
Long-term disease-free survivors in metastatic undifferentiated carcinoma of nasopharyngeal type
A Fandi et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
分享论文
